Literature DB >> 26887628

Thrombopoietic status of patients on haemodialysis.

Taha Bat1, Betul E Bat1, Ahmed El-Moghraby1, Samir Patel1, Xingmin Feng2, Cynthia E Dunbar2, Erdal Sarac1.   

Abstract

Thrombocytopenia is a potential dialysis-related treatment complication. Developments in bio-compatible dialyser membranes have decreased the occurrence of thrombocytopenia. We investigated whether thrombopoiesis is impaired in haemodialysis patients by measuring the thrombopoietin level and absolute immature platelet number (AIPN) in the blood of patients undergoing haemodialysis. Samples were collected from the dialysis tubing pre- and post- haemodialysis in a cohort of 45 well-characterized haemodialysis patients. Thrombopoietin levels and AIPN increased following haemodialysis, despite no change in platelet count. Observed increase in release of immature platelets from the bone marrow following haemodialysis indicates possible complement activation secondary to interaction between blood constituents and the dialysis membrane.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  IL1A (IL1α); absolute immature platelet number; haemodialysis; immature platelet fraction; thrombopoietin

Mesh:

Substances:

Year:  2016        PMID: 26887628      PMCID: PMC4785056          DOI: 10.1111/bjh.13918

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

Review 1.  Clinical implications of biocompatibility in blood purification membranes.

Authors:  R M Hakim
Journal:  Nephrol Dial Transplant       Date:  2000       Impact factor: 5.992

2.  Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.

Authors:  Mercedeh Kiaii; Ognjenka Djurdjev; Myriam Farah; Adeera Levin; Beverly Jung; Jennifer MacRae
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

3.  Dynamic visualization of thrombopoiesis within bone marrow.

Authors:  Tobias Junt; Harald Schulze; Zhao Chen; Steffen Massberg; Tobias Goerge; Andreas Krueger; Denisa D Wagner; Thomas Graf; Joseph E Italiano; Ramesh A Shivdasani; Ulrich H von Andrian
Journal:  Science       Date:  2007-09-21       Impact factor: 47.728

4.  Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.

Authors:  Sarah J Barsam; Bethan Psaila; Marc Forestier; Lemke K Page; Peter A Sloane; Julia T Geyer; Glynis O Villarica; Mary M Ruisi; Terry B Gernsheimer; Juerg H Beer; James B Bussel
Journal:  Blood       Date:  2011-03-09       Impact factor: 22.113

5.  New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels.

Authors:  M Ando; Y Iwamoto; A Suda; K Tsuchiya; H Nihei
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

6.  Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.

Authors:  B Psaila; J B Bussel; A L Frelinger; B Babula; M D Linden; Y Li; M R Barnard; C Tate; E J Feldman; A D Michelson
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

Review 7.  Effects of hemodialysis on cardiac function.

Authors:  Christopher W McIntyre
Journal:  Kidney Int       Date:  2009-06-10       Impact factor: 10.612

8.  Hemodialysis-associated platelet activation and thrombocytopenia.

Authors:  R M Hakim; A I Schafer
Journal:  Am J Med       Date:  1985-04       Impact factor: 4.965

9.  Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.

Authors:  L Grkovic; K Baird; S M Steinberg; K M Williams; D Pulanic; E W Cowen; S A Mitchell; F T Hakim; K J Martires; D N Avila; T N Taylor; R B Salit; S D Rowley; D Zhang; D H Fowler; M R Bishop; R E Gress; S Z Pavletic
Journal:  Leukemia       Date:  2011-10-18       Impact factor: 11.528

10.  IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs.

Authors:  Satoshi Nishimura; Mika Nagasaki; Shinji Kunishima; Akira Sawaguchi; Asuka Sakata; Hiroyasu Sakaguchi; Tsukasa Ohmori; Ichiro Manabe; Joseph E Italiano; Tomiko Ryu; Naoya Takayama; Issei Komuro; Takashi Kadowaki; Koji Eto; Ryozo Nagai
Journal:  J Cell Biol       Date:  2015-05-11       Impact factor: 10.539

View more
  2 in total

1.  Comparative analysis of the long-term effect of two families of high-flux polysulfone dialysers on platelet count: a retrospective cross-sectional study.

Authors:  Rosaria Del Giorno; Lorenzo Berwert; Silvio Pianca; Giorgia Bianchi; Olivier Giannini; Luca Gabutti
Journal:  Ther Clin Risk Manag       Date:  2017-10-16       Impact factor: 2.423

2.  Does Hemodialysis Need to be Initiated to Improve Platelet Function in CKD G5 Patients? A Pilot Prospective, Observational Cohort Study.

Authors:  Vinod B Murakonda; Anjali Mohapatra; Tulasi Geevar; Ramya Vijayan; Shailesh Kakde; Shibu Jacob; Suceena Alexander; Vinoi G David; Sukesh C Nair; Santosh Varughese; Anna T Valson
Journal:  Indian J Nephrol       Date:  2020-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.